alogliptin
Ligand Summary
a selective, orally bioavailable inhibitor of the enzymatic activity of dipeptidyl peptidase-4 (DPP-4) that slows the inactivation of the incretin hormones, thereby increasing their bloodstream concentrations and reducing fasting and postprandial glucose concentrations in a glucose-dependent manner in patients with type 2 diabetes mellitus
UNII: JHC049LO86
PubChem: 11450633
Guide to Pharmacology: 6319
ChEMBL: CHEMBL376359
DrugCentral: 4340
LyCHI: G78FTV835CTG
Target Activities
21 Activities
Items per page:
1 – 10 of 21
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
Kd | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||